Hagiwara et al., “Lymph Nodal Vital Staining with Newer Carbon Particle Suspensions Compared with Indla Ink: Experimetntal and Clinical Observations”, Lumphology 25 : 84-89 (1992).* |
Albertini et al., “Lymphatic mapping and sentinel node biopsy in the patient with breast cancer,” JAMA, 276:1818-1822, 1996. |
Anderson et al.,. “Tattoo pigment mimicking metastatic malignant melanoma,” Dermatol Surg., 22:92-94, 1996. |
Bilchik et al., “Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms,” Cancer J, 4:351-358, 1998. |
Bostick et al., “Intraoperative lymphatic mapping for early-stage melanoma of the head and neck,” Am J Surg, 174:536-539, 1997. |
Botoman et al., “Localization of colonic lesions with endoscopic tattoo,” Dis Colon Rectum, 37:775-776, 1994. |
Brandwood et al., “Phagocytosis of carbon particles by macrophages in vitro,” Biomaterials, 13:646-648, 1992. |
Eriguchi et al., “Regional lymph node metastasis of early gastric cancer,” Eur J Surg, 157:197-200, 1991. |
Fennerty et al., “Effectiveness of India ink as a long-term colonic mucosal marker,” Am J Gastroenterol, 87:79-81, 1992. |
Gershenwald et al., “Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage 1 or II melanoma,” J. Clin Oncol, 16:2253-2260, 1998. |
Giuliano et al., “Sentinel lymphadenectomy in breast cancer,” J Clin Oncol, 15:2345-2350, 1997. |
Giuliano et al., “Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer”, Annals of Surgery, 220(3):391-401, 1994. |
Glass et al., “Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma,” J Nucl Med, 39: 1185-1190, 1998. |
Hagiwara et al., “A pilot study of fiberscopy-guided local injection of anti-cancer drugs bound to carbon particles for control of rectal cancer,” ABSTRACT, Anticancer Drugs, 9(4):363-367, 1998. |
Hagiwara et al., “Activated carbon particles as an anti-cancer drug carrier into regional lymph nodes,” ABSTRACT, Anticancer Drug Des., 1(4):313-321, 1987. |
Hagiwara et al., “Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases,” Anticancer Res, 6:1005-1008, 1986. |
Hagiwara et al., “Local injection if anti-cancer drugs bound to carbon particles for early gastric cancer—a pilot study,” ABSTRACT, Hepatogastroenterology, 47(32):575-578, 2000. |
Imanishi et al., “Trial of a treatment for lymph nodes in metastases in patients with breast cancer using aclarubic in bound to activated carbon particles,” ABSTRACT, Gan To Kaguku Ryoho, 22(11):1635-1637, 1995. |
Kapteijn et al., “Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye,” Ann Surg Oncol, 4:156-160, 1997. |
Kelley et al., “Lymphatic mapping and sentinel lymphadenectomy for melanoma,” Semin Surg Oncol, 14:283-290, 1998. |
Kitamura et al., “Activated carbon-oriented gastrectomy for early gastric cancer,” Br J Surg, 82:647-650, 1995. |
Kitamura et al., “Rapid and accurate method for delineating cancer lesions in laparoscopic colectomy using activated carbon injection,” J Surg Oncol, 58:31-34, 1995. |
Kodama and Koyama, “Indications for pylorus preserving gastrectomy for early gastric cancer located in the middle third of the stomach,” World J Surg 15:628-634, 1991. |
Kodama et al., “Study on the lymphatic flow of the lower gastric region for radical lymphadenectomy in advanced lower gastric cancer,” ABSTRACT, Nippon Geka Gakkai Zasshi, 89(7):1008-1013, 1988. |
Krag et al., “Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe,” Surg Oncol, 2:335-340, 1993. |
Lucci et al., “Carbon dye as an adjunct to isosulfan blue for sentinel lymph node dissection,” Surgery, 126:48-53, 1999. |
Margevicius et al., “Identification and distribution of synthetic ligament wear particles in sheep,” J Biomed Mater Res, 31:319-328, 1996. |
Morton and Bostick, “Will the true sentinel node please stand?” Ann Surg Oncol, 6:12-14, 1999. |
Morton and Chan, “Current status of intranperative lymphatic mapping and sentinel lyniphadenectotny for melanoma: is it standard of care?” J Am Coll Surg, 189:214-223, 1999. |
Morton et al., “Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck,” J. Clin. Oncol., 11:1751-1756, 1993. |
Morton et al., “Symposium: lymphatic mapping and sentinel node biopsy in patients with breast cancer and melanoma,” Contemp Surg, 53:281-298 (part 1) 1998. |
Morton et al., “Symposium: lymphatic mapping and sentinel node biopsy in patients with breast cancer and melanoma,” Contemp Surg, 53:353-361 (part 2), 1998. |
Morton et al., “Technical details of intraoperative lymphatic mapping for early stage melanoma,” Arch Surg, 127:392-399, 1992. |
Morton, “Intraoperative lymphatic mapping and sentinel lymphadenectomy: Community standard care or clinical investigation?” Cancer J Sci. Am., 3:328-330, 1997. |
Nagakawa et al., “Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas,” Cancer, 73:1155-1162, 1994. |
Ohyama et al., “Endoscopic injection of methotrexate bound to activated carbon particles in the treatment of gastric cancer,” ABSTRACT, Gan To Kagaku Ryoho, 22(11) 1632-1634, 1995. |
Okamoto et al., “Number and anatomical extent of lymph node metastases in gastric cancer: analysis using intra-lymph node injection of activated carbon particles,” ABSTRACT, Jpn. J. Clin. Oncol., 29(2)74-77, 1999. |
Ponsky and King, “Endoscopic marking of colonic lesions,” Gastrointestinal Endoscopy 22:42-43, 1975. |
Sawai et al., “Rationale of lymph node dissection for breast cancer from the viewpoint of analysis of axillary lymphatic flow using activated carbon particle CH40,” ABSTRACT, Gan To Kagaku Ryoho, 23 Suppl 1:30-35, 1996. |
Sawai et al., “Rationalization of lymph node dissection for gastric cancer using small sized activated carbon particles absorbing absolute ethanol,” ABSTRACT, Nippon Geka Gakkai Zasshi, 90(9):1310-1313, 1989. |
Strom et al., “Retention and clearance of inhaled submicron black particles,” J Toxicol Environ Health, 26:183-202, 1989. |
Takahashi et al., “Studies on para-aortic metastatic lymph nodes in gastric cancer after endoscopic injection of activated carbon particles,” ABSTRACT, Nippon Geka Gakkai Zasshi, 88(1):35-40, 1987. |
Takahashi et al., “Type-oriented therapy for gastric cancer effective for lymph node metastasis: management of lymph node metastasis using carbon particles adsorbing an anticancer agent,” Semin Surg Oncol, 7:378-383, 1991. |
van der Veen et al., “Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy,” Br J Surg, 81:1769-1770, 1994. |
Veronesi et al., “Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes,” Lancet, 349:1864-1867, 1997. |
Wong et al., “Lymphatic drainage of skin to a sentinel lymph node in a feline model,” Ann Surg, 214:637-641, 1991. |
Yokota et al., “Lymph-node staining with activated carbon CH40: a new method for axillary lymph-node dissection in breast cancer,” Can J Surg, 43:191-196, 2000. |
Yoshida et al., “Studies on gastric lymphatics by using activated carbon particle (CH44) and lymph node metastasis of gastric cancer,” ABSTRACT, Nippon Geka Gakkai Zasshi, 89(5):664-670, 1988. |